Search Results - "Temel, Ryan"
-
1
ABCG5 and ABCG8: more than a defense against xenosterols
Published in Journal of lipid research (01-07-2018)“…The elucidation of the molecular basis of the rare disease, sitosterolemia, has revolutionized our mechanistic understanding of how dietary sterols are…”
Get full text
Journal Article -
2
Hepatic or intestinal ABCG5 and ABCG8 are sufficient to block the development of sitosterolemia1
Published in Journal of lipid research (01-02-2015)Get full text
Journal Article -
3
A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion
Published in Trends in pharmacological sciences (Regular ed.) (01-07-2015)“…Highlights • RCT involves both biliary and non-biliary pathways. • The non-biliary pathway normally constitutes ∼30% of RCT, but it can be stimulated. • Flux…”
Get full text
Journal Article -
4
Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis
Published in The Journal of clinical investigation (01-07-2011)“…Plasma HDL levels have a protective role in atherosclerosis, yet clinical therapies to raise HDL levels have remained elusive. Recent advances in the…”
Get full text
Journal Article -
5
Research Advances in Abdominal Aortic Aneurysms: Triglyceride-Rich Lipoproteins as a Therapeutic Target
Published in Arteriosclerosis, thrombosis, and vascular biology (01-06-2024)Get full text
Journal Article -
6
Stigmasterol stimulates transintestinal cholesterol excretion independent of liver X receptor activation in the small intestine
Published in The Journal of nutritional biochemistry (01-02-2020)“…Despite advances in healthcare, cardiovascular disease (CVD) remains the leading cause of death in the United States. Elevated levels of plasma cholesterol are…”
Get full text
Journal Article -
7
XX sex chromosome complement promotes atherosclerosis in mice
Published in Nature communications (14-06-2019)“…Men and women differ in circulating lipids and coronary artery disease (CAD). While sex hormones such as estrogens decrease CAD risk, hormone replacement…”
Get full text
Journal Article -
8
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides
Published in Nature (London) (20-10-2011)“…Manipulating plasma lipids Recent work in mice has shown that microRNA-33a is an important regulator of lipid metabolism and that its inhibition can increase…”
Get full text
Journal Article -
9
Biliary and nonbiliary contributions to reverse cholesterol transport
Published in Current opinion in lipidology (01-04-2012)“…The process of reverse cholesterol transport (RCT) is critical for disposal of excess cholesterol from the body. Although it is generally accepted that RCT…”
Get full text
Journal Article -
10
Paradoxical Suppression of Atherosclerosis in the Absence of microRNA-146a
Published in Circulation research (04-08-2017)“…RATIONALE:Inflammation is a key contributor to atherosclerosis. MicroRNA-146a (miR-146a) has been identified as a critical brake on proinflammatory nuclear…”
Get full text
Journal Article -
11
Cholesterol and Lipoprotein Metabolism: Early Career Committee Contribution
Published in Arteriosclerosis, thrombosis, and vascular biology (01-09-2014)Get full text
Journal Article -
12
BMP7 Drives Human Adipogenic Stem Cells into Metabolically Active Beige Adipocytes
Published in Lipids (01-02-2015)“…Adult humans have a substantial amount of inducible-brown (or beige) fat, which is associated with increased energy expenditure and reduced weight gain via…”
Get full text
Journal Article -
13
The prorenin receptor and its soluble form contribute to lipid homeostasis
Published in American journal of physiology: endocrinology and metabolism (01-03-2021)“…Obesity is associated with alterations in hepatic lipid metabolism. We previously identified the prorenin receptor (PRR) as a potential contributor to liver…”
Get more information
Journal Article -
14
Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing peroxisome proliferator-activated receptor α and fundamentally changing lipid metabolism
Published in Cardiovascular research (07-08-2023)“…Abstract Aims The metabolic failure of macrophages to adequately process lipid is central to the aetiology of atherosclerosis. Here, we examine the role of…”
Get full text
Journal Article -
15
Association of NOTCH3 With Elastic Fiber Dispersion in the Infrarenal Abdominal Aorta of Cynomolgus Monkeys
Published in Arteriosclerosis, thrombosis, and vascular biology (01-12-2023)“…The regional heterogeneity of vascular components and transcriptomes is an important determinant of aortic biology. This notion has been explored in multiple…”
Get full text
Journal Article -
16
Surface Engineered Polymersomes for Enhanced Modulation of Dendritic Cells During Cardiovascular Immunotherapy
Published in Advanced functional materials (01-10-2019)“…The principle cause of cardiovascular disease (CVD) is atherosclerosis, a chronic inflammatory condition characterized by immunologically complex fatty lesions…”
Get full text
Journal Article -
17
The LXR–Idol Axis Differentially Regulates Plasma LDL Levels in Primates and Mice
Published in Cell metabolism (04-11-2014)“…The LXR-regulated E3 ubiquitin ligase IDOL controls LDLR receptor stability independent of SREBP and PCSK9, but its relevance to plasma lipid levels is…”
Get full text
Journal Article -
18
Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin
Published in The Journal of clinical investigation (01-02-2012)“…Hypercholesterolemia is a major risk factor for atherosclerosis. It also is associated with platelet hyperactivity, which increases morbidity and mortality…”
Get full text
Journal Article -
19
The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance
Published in Cell reports (Cambridge) (20-01-2015)“…Circulating levels of the gut microbe-derived metabolite trimethylamine-N-oxide (TMAO) have recently been linked to cardiovascular disease (CVD) risk. Here, we…”
Get full text
Journal Article -
20
Targeting hepatic heparin-binding EGF-like growth factor (HB-EGF) induces anti-hyperlipidemia leading to reduction of angiotensin II-induced aneurysm development
Published in PloS one (09-08-2017)“…The upregulated expression of heparin binding EGF-like growth factor (HB-EGF) in the vessel and circulation is associated with risk of cardiovascular disease…”
Get full text
Journal Article